PCSK9 and asthma: In addition to confirming the expected associations with various forms of occlusive CVD, we further identified that PCSK9-GS, orientated to a lowering of LDL-C, was associated with a higher risk of URTI, acute exacerbations of COPD, and self-reported asthma.